Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

Wed, 05th Dec 2018 08:44

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US Treasury yields dropped below zero.

Traders were sceptical around the Trump-Xi agreement announced over the weekend.

In China, traders paid little attention to encouraging services data. The benchmark Shanghai Composite index fell 16.15 points or 0.6% to 2,649.81 while Hong Kong's Hang Seng index tumbled 1.6% to close at 26,819.68.

The services sector in China continued to expand in November, and at an accelerated rate, the latest survey from Caixin revealed with a PMI score of 53.8. That beat expectations for 50.8, which would have been unchanged from the October reading.

Japanese shares fell after a plunge on Wall Street overnight on growth and trade concerns. The Nikkei average shed 116.72 points or 0.5% to finish at 21,919.33, while the broader Topix index closed 0.5% lower at 1,640.49.

China-focused shares ended lower, with Fanuc losing 3.4% and Rohm declining 1.5%. In the tech sector, Advantest slumped 4.6% and Tokyo Electron shed 1.8%.

Drug giant Takeda rose 1.1% after it received shareholder approval to acquire Irish pharmaceuticals firm Shire in a deal worth around USD60 billion.

On the economic front, the latest survey from Nikkei showed that the services sector in Japan continued to expand in November, albeit at a fractionally slower pace with a PMI score of 52.3, down from 52.4 in October.

Australian markets hit a two-week low before ending off their day's lows, dragged down by banks after official data showed the economy slowed more than expected in the third quarter of 2018.

Australia's GDP grew a seasonally adjusted 0.3% sequentially in the last quarter, missing expectations for an increase of 0.6% and down from 0.9% in the second quarter. On a yearly basis, GDP expanded 2.8% - again missing forecasts for 3.3% and down from 3.4% in the three months prior.

Another report from the Australian Industry Group revealed that the service sector in Australia continued to expand in November, and at a sharply faster rate.

The benchmark S&P/ASX 200 index ended down 44.70 points or 0.8% at 5,668.40 after losing 1.0% in the previous session. The broader All Ordinaries index dropped 48.40 points or 0.8% to 5,749.10

The big four banks fell between 0.7% and 1.2%. Mining heavyweights BHP Billiton and Rio Tinto rose modestly while energy majors Oil Search, Origin Energy, Beach Energy and Santos lost around 2% as oil resumed declines in Asian trade.

Rare earths miner Lynas Corp plummeted 22% after tough new conditions were announced for the company's license to operate in Malaysia.

Seoul stocks recovered some lost ground after hitting over one-week low earlier in the day. The benchmark Kospi fell over 1% before recouping some loss to end the session down 13.04 points or 0.6% at 2,101.31 on continued uncertainty over the Sino-US trade war.

New Zealand shares fell sharply as a flattening Treasury yield curve and doubts about the durability of the US-China trade war truce sparked worries about global growth.

The benchmark S&P/NZX 50 index dropped 84.23 points or 1.0% to finish at 8,781.53. Trade Me shares bucked the weak trend to end 3.1% higher after a second bidder emerged for the e-commerce leader.

Singapore's Straits Times index was down 0.6%. The country's private sector continued to expand in November, and at a faster rate, the latest survey from Nikkei showed with a PMI score of 53.8, up from 52.6 in October.

Overnight, US stocks tanked as the initial euphoria generated by a truce between the US and China over trade evaporated and an inverted yield curve in bond markets signalled an economic slowdown.

The Dow Jones Industrial Average tumbled 3.1%, the tech-heavy Nasdaq Composite plummeted 3.8% and the S&P 500 lost 3.2%.

More News
25 Oct 2018 15:20

TOP NEWS: Shire Seeks US Approval To Make Flexbumin At New Facility

LONDON (Alliance News) - Pharmaceutical company Shire PLC on Thursday said it has filed a submission to the US Food & Drug Administration for approval to manufacture Flexbumin at its new is as

Read more
23 Oct 2018 16:25

MOVES-JPMorgan reshuffles healthcare group, co-head departs -sources

By Greg Roumeliotis and Liana B. Baker Oct 23 (Reuters) - JPMorgan Chase & Co has appointed Mike Gaito as global co-head of healthcare investment banking after Jeff Stute, who held that

Read more
19 Oct 2018 14:38

Shire's lanadelumab gets one step closer to European approval

(Sharecast News) - Rare disease-focussed biotechnology company Shire announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing authorisation of 'lanadelumab' injection, for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.

Read more
18 Oct 2018 09:26

UPDATE 1-Takeda gets Japanese approval for $62 bln Shire purchase

Oct 18 (Reuters) - Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to a it

Read more
1 Oct 2018 11:24

Schroder Japan Growth Outperforms Benchmark In Full Year

LONDON (Alliance News) - Schroder Japan Growth Fund PLC said on Monday it outperformed its benchmark in its recently ended financial year due to a robust performance in the first half, in spite of

Read more
28 Sep 2018 06:23

UK Stocks-Factors to watch on Sept 28

Sept 28 (Reuters) - Britain's FTSE 100 index is seen opening 8 points higher at 7,553 on Friday, according to financial bookmakers. * SHIRE: Japan M&A volumes are set to break a 19-year-old

Read more
28 Sep 2018 04:09

Morning News Call - India, September 28

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_09282018.pdf If you would like to receive this newsletter via email, please at: TO

Read more
27 Sep 2018 17:53

UPDATE 1-FTSE rises to 4-week high helped by sterling weakness

* FTSE 100 up 0.5 pct * Higher crude lifts oil stocks, hits airlines * TUI sticks to forecasts, shares gain (Adds details, closing prices) By Danilo Masoni MILAN, Sept

Read more
21 Sep 2018 11:26

Shire Gets Japanese Approval For Rare Genetic Disease Drug Firazyr

LONDON (Alliance News) - Pharmaceutical company Shire PLC on Friday said it has been granted manufacturing and marketing authorisation in Japan for its hereditary angioedema drug, Japanese of has

Read more
21 Sep 2018 07:19

Shire gets approval for hereditary angioedema treatment in Japan

(Sharecast News) - Rare disease specialist Shire announced on Friday that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted manufacturing and marketing authorisation for its 'FIRAZYR' icatibant injection, for the acute treatment of hereditary angioedema (HAE) attacks in adult patients with HAE.

Read more
17 Sep 2018 06:41

UK Stocks-Factors to watch on Sept 17

Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers. * GOLD: Gold inched up on Monday as bargain-hunters bought the metal after prices

Read more
14 Sep 2018 17:28

UPDATE 1-FTSE tracks Europe higher; Shire shines

* FTSE 100 up 0.3 pct * Shire gains after China nod to Takeda deal * Housebuilders in focus * Investec rallies on spin-off plans (Adds closing) By Danilo Sept 14 - top

Read more
14 Sep 2018 12:01

LONDON MARKET MIDDAY: Stocks Higher As Shire And Whitbread Gain

LONDON (Alliance News) - Stocks in London were higher at midday on Friday with Shire and Whitbread performing well among FTSE 100 constituents, while in the FTSE was

Read more
14 Sep 2018 10:32

WINNERS & LOSERS SUMMARY: Housebuilders Hit By No-Deal Brexit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 1.8%. Takeda Pharmaceutical said it had in of

Read more
14 Sep 2018 10:16

FTSE tracks Europe higher on trade hopes; Shire shines

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Shire gains after China nod to Takeda deal * Housebuilders under Investec on -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.